delays Myc-driven prostate cancer progression in the Hi-Myc transgenic mouse model. METHODS: miR-21 KO mice were backcrossed to FVB mice to generation F10. Resulting miR-21 WT or KO FVB progeny were crossed with Hi-Myc mice to generate Hi-Myc/miR-21 WT or KO mice. Prostates were harvested at 4 weeks (n[10), 3 months (n[10), 5 months (n[58), 6 months (n[25), 8 months (n[20) of age and prostate weight, histology, miR-21 expression levels and protein expression levels were quantified. Proliferation and apoptosis were examined by immunohistochemistry using Ki-67 and cleaved caspase-3.
INTRODUCTION AND OBJECTIVES: Radiotherapy-induced normal tissue damage in rectum and bladder remains the largest doselimiting factor for treatment of prostate cancer (PCa). 5-aminolevulinic acid (ALA) reportedly exerts a broad range of cytoprotective effects, for example, against cisplatin-induced nephrotoxicity. Here, we investigated the supplementary oral 5-aminolevulinic acid (ALA) to standard radiation therapy as a novel radioprotective approach that would not compromise the antitumor effect of radiation in normal rectal and bladder mucosa in a syngenic PCa model. METHODS: Myc-CaP cells were isolated from a c-myc transgenic FVB mouse with PCa. A syngenic PCa model of MyC-CaP cells was created by subcutaneous inoculation to the pelvic area. To evaluate the effect of ALA in vivo, multiple doses (12 Gy total) of radiation was delivered to the mouse pelvic area with or without 30 mg/kg/day of oral ALA for 28 days. Resected tumors, recta, and urinary bladders were subjected to immunostaining with Ki-67, g-H2AX, CD204, and uroplakin-III antibodies. Expression levels of mRNA in recta and urinary bladders were analyzed via RT2 Profiler qPCR arrays related to "Stress & Toxicity PathwayFinder 00 , "Mitochondria 00 , and "Inflammasomes 00 . RESULTS: The repeated oral administration of ALA exerted as a radiosensitizer for PCa cells ( Figure 1A) . Rectal toxicity was characterized by histological changes including loss of surface epithelium, fibrosis, severe DNA damage, and the aggregation of M2-polarized macrophages ( Figure 1B) . Urinary bladder toxicity was characterized by bladder wall thickening and urothelium denuding ( Figure 1C) . Out of the 252 genes tested, 35 (13.4%) were indentified as relevant genes which are involved in the radioprotective role of exogenous ALA. These genes included IL-1a, IL-1b, IL-12, CXCL1, CXCL3, and NLRP3.
CONCLUSIONS: The present study provides novel and comprehensive insights into the dual benefits including radiosensitizing PCa tumor tissues and radioprotection of normal pelvic organs from radiatiotherapy. Knowledge of the underlying mechanism will facilitate the search for optimal treatment parameters for supplemental oral ALA during radiotherapy for PCa.
